Literature DB >> 33150393

Impact of Nonpharmaceutical Interventions on the Incidence of Respiratory Infections During the Coronavirus Disease 2019 (COVID-19) Outbreak in Korea: A Nationwide Surveillance Study.

Kyungmin Huh1, Jaehun Jung2, Jinwook Hong2, MinYoung Kim3,4, Jong Gyun Ahn3, Jong-Hun Kim5, Ji-Man Kang3,4.   

Abstract

BACKGROUND: Many countries have implemented nonpharmaceutical interventions (NPIs) to slow the spread of coronavirus disease 2019 (COVID-19). We aimed to determine whether NPIs led to the decline in the incidences of respiratory infections.
METHODS: We conducted a retrospective, ecological study using a nationwide notifiable diseases database and a respiratory virus sample surveillance collected from January 2016 through July 2020 in the Republic of Korea. Intervention period was defined as February-July 2020, when the government implemented NPIs nationwide. Observed incidences in the intervention period were compared with the predicted incidences by an autoregressive integrated moving average model and the 4-year mean cumulative incidences (CuIs) in the same months of the preintervention period.
RESULTS: Five infectious diseases met the inclusion criteria: chickenpox, mumps, invasive pneumococcal disease, scarlet fever, and pertussis. The incidences of chickenpox and mumps during the intervention period were significantly lower than the prediction model. The CuIs (95% confidence interval) of chickenpox and mumps were 36.4% (23.9-76.3%) and 63.4% (48.0-93.3%) of the predicted values. Subgroup analysis showed that the decrease in the incidence was universal for chickenpox, while mumps showed a marginal reduction among those aged <18 years, but not in adults. The incidence of respiratory viruses was significantly lower than both the predicted incidence (19.5%; 95% confidence interval, 11.8-55.4%) and the 4-year mean CuIs in the preintervention period (24.5%; P < .001).
CONCLUSIONS: The implementation of NPIs was associated with a significant reduction in the incidences of several respiratory infections in Korea.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; South Korea; nonpharmaceutical intervention; respiratory infection; social distancing

Year:  2021        PMID: 33150393      PMCID: PMC7665442          DOI: 10.1093/cid/ciaa1682

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  27 in total

1.  Nationwide Implementation of Nonpharmaceutical Interventions During the Coronavirus Disease 2019 Pandemic Is Associated With Decreased Incidence of Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients.

Authors:  Keun Hyung Park; Chan-Young Jung; Wonjeong Jeong; Gongmyung Lee; Jae Seok Yang; Chung Mo Nam; Hyung Woo Kim; Beom Seok Kim
Journal:  Open Forum Infect Dis       Date:  2022-06-23       Impact factor: 4.423

2.  Association between the COVID-19 pandemic and pertussis derived from multiple nationwide data sources, France, 2013 to 2020.

Authors:  Soraya Matczak; Corinne Levy; Camille Fortas; Jérémie F Cohen; Stéphane Béchet; Fatima Aït El Belghiti; Sophie Guillot; Sabine Trombert-Paolantoni; Véronique Jacomo; Yann Savitch; Juliette Paireau; Sylvain Brisse; Nicole Guiso; Daniel Lévy-Bruhl; Robert Cohen; Julie Toubiana
Journal:  Euro Surveill       Date:  2022-06

Review 3.  Non-pharmaceutical interventions during the COVID-19 pandemic: A review.

Authors:  Nicola Perra
Journal:  Phys Rep       Date:  2021-02-13       Impact factor: 25.600

4.  Burden of whooping cough in China (PertussisChina): study protocol of a prospective, population-based case-control study.

Authors:  Jianxing Yu; Hanqing He; Yanyang Zhang; Yuan Gao; Chuanwei Chen; Juan Xu; Li Xu; Xiaoxiao Zhang; Qianqian Zhou; Yao Zhu; Xuewen Tang; Yonghao Guo; Zhiping Chen; Zhujun Shao
Journal:  BMJ Open       Date:  2022-03-10       Impact factor: 2.692

5.  Decline in mortality due to respiratory diseases in Japan during the coronavirus disease 2019 pandemic.

Authors:  Nobuyuki Horita; Hideaki Kato; Keisuke Watanabe; Yu Hara; Nobuaki Kobayashi; Takeshi Kaneko
Journal:  Respirology       Date:  2021-11-21       Impact factor: 6.424

6.  Trends in non-COVID-19 hospitalizations prior to and during the COVID-19 pandemic period, United States, 2017 â€" 2021.

Authors:  Kelsie Cassell; Casey M Zipfel; Shweta Bansal; Daniel M Weinberger
Journal:  medRxiv       Date:  2022-04-28

7.  Decrease in hospital admissions for respiratory diseases during the COVID-19 pandemic: a nationwide claims study.

Authors:  Kyungmin Huh; Young-Eun Kim; Wonjun Ji; Dong Wook Kim; Eun-Joo Lee; Jong-Hun Kim; Ji-Man Kang; Jaehun Jung
Journal:  Thorax       Date:  2021-03-29       Impact factor: 9.139

8.  Reduction in Kawasaki Disease After Nonpharmaceutical Interventions in the COVID-19 Era: A Nationwide Observational Study in Korea.

Authors:  Ji-Man Kang; Young-Eun Kim; Kyungmin Huh; Jinwook Hong; Dong Wook Kim; Min Young Kim; Se Yong Jung; Jong-Hun Kim; Jaehun Jung; Jong Gyun Ahn
Journal:  Circulation       Date:  2021-06-07       Impact factor: 29.690

9.  Impact of non-pharmaceutical interventions on the incidences of vaccine-preventable diseases during the COVID-19 pandemic in the eastern of China.

Authors:  Xiang Sun; Yan Xu; Yuanyuan Zhu; Fenyang Tang
Journal:  Hum Vaccin Immunother       Date:  2021-08-10       Impact factor: 4.526

10.  The incremental burden of invasive pneumococcal disease associated with a decline in childhood vaccination using a dynamic transmission model in Japan: A secondary impact of COVID-19.

Authors:  Taito Kitano; Hirosato Aoki
Journal:  Comput Biol Med       Date:  2021-04-24       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.